Inhaled hydroxychloroquine to improve efficacy and reduce harm in the treatment of COVID-19

Current formulations and dose regimens of hydroxychloroquine (HCQ) put patients at risk of harm. An analysis of clinical trials registered on ClinicalTrials.gov revealed that this may continue as many studies combine HCQ with agents that prolong the QT interval. Further, almost all of the trials reg...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Med Hypotheses
Main Authors: Kavanagh, Oisín, Marie Healy, Anne, Dayton, Francis, Robinson, Shane, O'Reilly, Niall J., Mahoney, Brian, Arthur, Aisling, Walker, Gavin, Farragher, John P.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier Ltd. 2020
Assuntos:
Letter to Editors
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7361049/
https://ncbi.nlm.nih.gov/pubmed/33017904
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mehy.2020.110110
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados